Delegation Program
The program will be finalized based on the composition of the delegation, stakeholder availability and participating companies’ priorities. The agenda below is indicative and subject to change. Activities, hosts and formats will be confirmed as the program develops.
| Day | Location | Theme | Agenda highlights |
Day 1 | Thu 4 March | Hong Kong | Ecosystem and clinical research | •09:00 Welcoming briefing by Business Sweden •10:30 Hong Kong biotech ecosystem dialogue •14:00 Visit to HSITP, incl. AstraZeneca Hong Kong and the GBA International Clinical Trial Institute |
Day 2 | Fri 5 March | Hong Kong | Investors and industry | •09:00 / 10:30 / 14:00 Meetings with three biotech investors – pipeline pitches, financing criteria and market insights •16:00 Pharmaceutical / biotech industry dialogue on collaboration and co-development |
Sat–Sun | 6–7 March | HK / Shanghai | Free weekend | •Outside programme scope – participants travel to Shanghai by 7 March at their own arrangement |
Day 3 | Mon 8 March | Shanghai | Investors, R&D and clusters | •09:30 Meeting with a biotech investor •11:00 Meeting with AstraZeneca China R&D •13:30 Meeting with a leading biotech company in China #1 •15:00 Visit to Zhangjiang Biotech Park |
Day 4 | Tue 9 March | Shanghai → Suzhou | Industry, legal and networking | •09:30 Meeting with a leading biotech company in China #2 •11:00 Meeting with a leading legal adviser in the biotech sector •12:30 Networking lunch hosted by the Consulate General of Sweden in Shanghai •Afternoon: free time; high-speed train to Suzhou |
Wed–Fri | 10–12 March | Suzhou | BIOCHINA 2027 | •Morning bus from hotel in Suzhou to BIOCHINA; conference and exhibition access for the pass holder •Each company submits its own meeting requests via the BIOCHINA’s official platform – acceptance rests with the counterpart •Compact shared Swedish booth (approx. 9 sqm) focused on company logos, video promotion and use as a common meeting point •Possible side visit to a company in Suzhou (TBC, one day only) |
Target Stakeholder Types
The stakeholder program will be developed based on the composition and priorities of the delegation, as well as stakeholder relevance, interest and availability.
The following stakeholder types are illustrative and do not represent confirmed meetings or participating organizations:
- Investors and industry partners, including life science investors, pharmaceutical companies and biotechnology companies
- Research and innovation stakeholders, including universities, research institutes, science parks, biotech clusters and innovation platforms
- Industry experts and professional advisers, including specialists in intellectual property, partnering, transactions, financing and relevant industry developments
Specific organizations and engagements will be confirmed as the program develops and remain subject to stakeholder interest and availability.
